Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer
Cancers · 16.06.2023 · 15 (12) · 3221
DOI: 10.3390/cancers15123221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 16.06.2023. Verfasst von Lisha Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Science and Technology Department, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Although immune checkpoint inhibitors improved the clinical outcomes of advanced triple negative breast cancer (TBNC) patients, the response rate remains relatively low. Nigericin is an antibiotic derived from Streptomyces hydrophobicus. We found that nigericin caused cell death in TNBC cell lines MDA-MB-231 and 4T1 by inducing concurrent pyroptosis and apoptosis. As nigericin facilitated cellular potassium efflux, we discovered that it caused mitochondrial dysfunction, leading to mitochondrial ROS production, as well as activation of Caspase-1/GSDMD-mediated pyroptosis and Caspase-3-mediated apoptosis in TNBC cells. Notably, nigericin-induced pyroptosis could amplify the anti-tumor immune response by enhancing the infiltration and anti-tumor effect of CD4+ and CD8+ T cells. Moreover, nigericin showed a synergistic therapeutic effect when combined with anti-PD-1 antibody in TNBC treatment. Our study reveals that nigericin may be a promising anti-tumor agent, especially in combination with immune checkpoint inhibitors for advanced TNBC treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Chi…
- Department of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
- South China National Bio-Safety Laboratory, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510600, China.
- Department of Breast Oncology, The Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
- Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, Foshan 528200, China.
ORCID-Profile: Man-Li Luo
Förderung
- National Natural Science Foundation of China
- Guangdong Science and Technology Department
- Natural Science Foundation of Guangdong Province
- Beijing Xisike Clinical Oncology Research Foundation
- Basic Research and Application of Guangzhou Science and Technology Planning Project
- Natural Science Foundation of China
Zitieren
APA
Wu, L., Bai, S., Huang, J., Cui, G., Li, Q., Wang, J., Du, X., Fu, W., Li, C., Wei, W., Lin, H., & Luo, M. L. (2023). Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer. Cancers, 15(12), 3221. https://doi.org/10.3390/cancers15123221
Vancouver
Wu L, Bai S, Huang J, Cui G, Li Q, Wang J, et al. Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer. Cancers. 2023;15(12):3221. doi:10.3390/cancers15123221
BibTeX
@article{Wu2023,
author = {Wu, Lisha and Bai, Shoumin and Huang, Jing and Cui, Guohui and Li, Qingjian and Wang, Jingshu and Du, Xin and Fu, Wenkui and Li, Chuping and Wei, Wei and Lin, Huan and Luo, Man-Li},
title = {Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer},
journal = {Cancers},
year = {2023},
volume = {15},
number = {12},
pages = {3221},
doi = {10.3390/cancers15123221}
}
EUVIMED